Breaking News, Financial News

Financial Report: Sanofi-Aventis 3Q

Sanofi-Aventis 3Q

3Q Revenues: $8.8 billion (-1%)

3Q Earnings: $1.5 billion

YTD Revenues: $26.7 billion (+3%)

YTD Earnings: $4.4 billion (+100%)

Comments: 3Q net sales for the pharmaceuticals business were hit hard by the introduction of generic versions of four products in the U.S. and the effect of healthcare system reforms in France and Germany, falling by 0.4% to $8.0 billion. Net sales of the top 15 products advanced by 1.5% to $5.4 billion, representing 67.5% of pharmaceuticals net sales, against 66.2% for the comparable period in 2005.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters